European Glaucoma Prevention Study: Author reply

@article{Miglior2005EuropeanGP,
  title={European Glaucoma Prevention Study: Author reply},
  author={S. Miglior and N. Pfeiffer and T. Zeyen and J. Cunha-Vaz and V. Torri and I. Adamsons},
  journal={Ophthalmology},
  year={2005},
  volume={112},
  pages={1643-1645}
}

Topics from this paper

Relationship of change in central corneal thickness to visual field progression in eyes with glaucoma
TLDR
Thinner baseline central corneal thickness was associated with more advanced damage at presentation and CCT reduced slightly over time in eyes with glaucoma; but the magnitude of this change was not related to visual field progression. Expand
Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma
TLDR
The effect of reducing intraocular pressure on the incidence of primary open‐angle glaucoma (POAG) in patients with ocular hypertension (OH) and the progression of glAUcoma is estimated. Expand
Estudo das correlações entre a área do disco óptico e as características geométricas e biomecânicas da córnea
TLDR
There is a negative correlation between optic disc size and corneal thickness and biomechanical properties, which may help explaining susceptibility for the development of glaucoma neuropathy in some cases. Expand
A simplified combined index of structure and function for detecting and staging glaucomatous damage
TLDR
A simplified combined structure–function index (sCSFI) could improve the detection and staging of glaucomatous damage, compared to the use of average retinal nerve fiber layer thickness (RNFL) measurements from OCT and mean deviation values from SAP alone, and also an estimated retinal ganglion cell counts (eRGC) measure derived using empirical formulas. Expand
Risk factors for open-angle glaucoma and recommendations for glaucoma screening
TLDR
The epidemiology and risk factors for the development of open-angle glaucoma are discussed and the screening procedure according to the recently published S2e guidelines of the Association of the Scientific Medical Societies in Germany (AWMF) is presented. Expand
The Association Between Intraocular Pressure and Visual Field Worsening in Treated Glaucoma Patients
TLDR
In treated eyes, IOP remained associated with worsening in eyes the more advanced glaucoma throughout the IOP range but was only associated with worsened in eyes with less severe glau coma at higher IOP. Expand
A neuroglia-based interpretation of glaucomatous neuroretinal rim thinning in the optic nerve head
TLDR
A better understanding of glaucomatous glial response may lead to glia-targeting neuroprotection in the future, and updated understandings on glial responses illustrate the mechanical, microenvironmental, and microglial modulation of activated astrocytes inglaucoma. Expand
Clinical Efficacy and Safety Outcomes of Micropulse Trans-Scleral Diode Cyclophotocoagulation in Patients with Advanced Glaucoma.
TLDR
Single first-time MPTCP for advanced glaucoma eyes was moderately effective in lowering intraocular pressure but >50% failed by one year. Expand
Effect of intraocular pressure lowering on the capillary density of optic nerve head and retinal nerve fiber layer in patients with glaucoma.
TLDR
The glaucomatous eyes presented rarefaction of the radial papillary capillaries density in the inferior sectors, but no significant changes in the density after IOP-lowering medications. Expand
Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
TLDR
This study is the first to show promising effects of PEA on PERG and on quality of life in glaucoma patients and to record effects on intraocular pressure, visual field andquality of life. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 10 REFERENCES
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
TLDR
Topical ocular hypotensive medication was effective in delaying or preventing the onset of POAG in individuals with elevated IOP, and clinicians should consider initiating treatment for individuals with ocular hypertension who are at moderate or high risk for developing POAG. Expand
Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
TLDR
Bimonidine suppressed aqueous humor flow, but not as effectively as timolol, and the effects on the IOP of both drugs separately were comparable, suggesting an additional mechanism for the ocular hypotensive effect of brimonidine. Expand
Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial
TLDR
A tendency but failed to prove a beneficial effect of topical timolol treatment in patients with elevated IOP, normal visual fields and some additional risk factor is found. Expand
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
  • M. F. Sugrue
  • Medicine
  • Progress in Retinal and Eye Research
  • 2000
There was a time gap of over 40 years between the demonstrated oral effectiveness of acetazolamide in lowering the intraocular pressure (IOP) of glaucoma patients and the introduction of a topicalExpand
The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
TLDR
Topically administered dorzolamide hydrochloride is effective for reducing the rate of aqueous humor flow in normal human eyes during the day and at night during sleep, approximately half that of systematically administered acetazolamide. Expand
Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans.
TLDR
Timolol is more effective than dorzolamide as a suppressor of aqueous humor flow in the normal human eye as compared with the effectiveness of 0.5% timolol maleate and both drugs are additive in their effects. Expand
The ocular hypertension treatment study.
  • M. Kass
  • Medicine
  • Journal of glaucoma
  • 1994
TLDR
To determine if there is a penalty for delaying treatment, the cumulative proportions of participants who developed POAG at a median follow-up of 13 years in the original observation group and the original medication group were compared. Expand
A comparison of treated and untreated glaucoma suspects.
TLDR
A significant correlation was found between initial cup-to-disc ratio and survival time to visual field defects in the untreated group and the time to failure of disc change was related to the mean IOP during the study and also to the changes in the IOP from baseline. Expand
A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects.
TLDR
The results demonstrate a favorable influence of timolol therapy on the clinical course of patients with mildly elevated IOP and a higher tonographic facility of outflow was protective in all analyses. Expand
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.
TLDR
Evidence that lowering intraocular pressure by medical treatment reduces the incidence of glaucomatous damage in ocular-hypertensive individuals is provided. Expand